A high triglyceride-glucose index associated with adverse cardiovascular events in patients with type 2 diabetes mellitus and chronic total occlusion after percutaneous coronary intervention

被引:8
|
作者
Lin, Xiao Long [1 ,2 ]
Li, Qiu Yu [1 ,2 ]
Zhao, Dong Hui [1 ,2 ]
Liu, Jing Hua [1 ,2 ]
Fan, Qian [1 ,2 ,3 ,4 ]
机构
[1] Capital Med Univ, Beijing AnZhen Hosp, Ctr Coronary Artery Dis, Beijing, Peoples R China
[2] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing AnZhen Hosp, Ctr Coronary Artery Dis, Beijing 100029, Peoples R China
[4] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
关键词
Triglyceride-glucose index; type 2 diabetes mellitus; chronic total occlusion; percutaneous coronary intervention; adverse cardiovascular outcomes; HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; CLINICAL-OUTCOMES; IMPACT; REVASCULARIZATION; SURROGATE; PRODUCT; RISK; CELL;
D O I
10.1177/10815589231152823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Triglyceride-glucose index (TyG index) is a reliable surrogate marker of insulin resistance, associated with morbidity and prognosis of cardiovascular disease. However, its predictive value for cardiovascular events in patients with type 2 diabetes mellitus (T2DM) and chronic total occlusion (CTO) after percutaneous coronary intervention (PCI) has not been studied. Here, we retrospectively enrolled 681 patients with T2DM and CTO after PCI. Patients were divided into two groups based on a median TyG index of 9.02. The TyG index was calculated as ln [fasting triglyceride (mg/dL) x fasting glucose (mg/dL)/2]. The primary observational end point was the composite of overall death, nonfatal myocardial infarction, and unplanned revascularization. The Multivariate Cox hazards regression analysis showed that the TyG index was significantly correlated with the primary end point (hazard ratio = 1.699, 95% confidence interval 1.254-2.303, p = 0.001). The addition of TyG to a baseline risk model had an incremental effect on the predictive value for the primary end point (area under the curve: TyG index vs baseline model, 0.693 vs 0.663, comparison p = 0.040; integrated discrimination improvement = 0.049, p = 0.020). The TyG index might be a predictor of adverse cardiovascular events. Moreover, adding the TyG index into a baseline risk model had a cumulative effect on the predictive potential for the primary end point.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 50 条
  • [31] A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention
    Shiqiang Xiong
    Qiang Chen
    Zhen Zhang
    Yingzhong Chen
    Jun Hou
    Caiyan Cui
    Lianchao Cheng
    Hong Su
    Yu Long
    Siqi Yang
    Lingyao Qi
    Xu Chen
    Hanxiong Liu
    Lin Cai
    Cardiovascular Diabetology, 21
  • [32] High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study
    Song, Yanjun
    Cui, Kongyong
    Yang, Min
    Song, Chenxi
    Yin, Dong
    Dong, Qiuting
    Gao, Ying
    Dou, Kefei
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [33] Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention
    Dong, Shutong
    Zhao, Zehao
    Huang, Xin
    Ma, Meishi
    Yang, Zhiqiang
    Fan, Chu
    Han, Hongya
    Wang, Zhijian
    Shi, Dongmei
    Zhou, Yujie
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [34] Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients
    Liu, Mao-Jun
    Pei, Jun-Yu
    Zeng, Cheng
    Xing, Ying
    Zhang, Yi-Feng
    Tang, Pei-Qi
    Deng, Si-Min
    Hu, Xin-Qun
    WORLD JOURNAL OF DIABETES, 2025, 16 (03)
  • [35] Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Left Ventricular Systolic Dysfunction Patients with and without Diabetes Mellitus
    Wu, Xi
    Li, Qin
    Wu, Mingxing
    Huang, Haobo
    Liu, Zhe
    Huang, He
    Wang, Lei
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (11)
  • [36] Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
    Guo, Qianyun
    Feng, Xunxun
    Zhang, Bin
    Zhai, Guangyao
    Yang, Jiaqi
    Liu, Yang
    Liu, Yuyang
    Shi, Dongmei
    Zhou, Yujie
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention
    Yu, Bingyan
    Mo, Yuhao
    Hu, Xiangming
    Wang, Weimian
    Liu, Jieliang
    Jin, Junguo
    Lun, Ziheng
    Luo Bu, Ci Ren
    Dong, Haojian
    Zhou, Yingling
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes
    Duan, Suyan
    Zhou, Meng
    Lu, Fang
    Chen, Chen
    Chen, Si
    Geng, Luhan
    Zhang, Chengning
    Guo, Honglei
    Zeng, Ming
    Sun, Bin
    Mao, Huijuan
    Zhang, Bo
    Xing, Changying
    Yuan, Yanggang
    ENDOCRINE, 2023, 81 (01) : 77 - 89
  • [39] Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
    Tao, Shiyi
    Yu, Lintong
    Li, Jun
    Huang, Li
    Huang, Xuanchun
    Zhang, Wenjie
    Xie, Zicong
    Tan, Yuqing
    Yang, Deshuang
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [40] Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study
    Wang, Yue
    Wang, Yue
    Sun, Shuaifeng
    Liu, Xinyan
    Zhao, Wenxin
    Li, Wenzheng
    Suo, Min
    Wu, Zheng
    Wu, Xiaofan
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)